
|Articles|November 22, 2004
Hyaluronidase product hailed as welcome revival of old drug
Nationwide drug shortages, many of which are caused by manufacturing problems, often leave hospital-based healthcare professionals in a bind. A few years ago, when Wyeth-Ayerst announced the imminent unavailability of hyaluronidase (Wydase), it sent shock waves throughout the hospital community.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Gaps Between Expectations and Effects on Long COVID Contribute to Trust in Vaccines
2
Cardiovascular Disease Rates Increase for Patients With Mental Disorders During COVID-19 Pandemic
3
American Pharmacists Month: How Community Pharmacy Innovation Relies on Expansion, Collaboration
4
How Pharmacies’ Ability to Provide Behavioral Health Services is Growing | NCPA 2025
5


























































































































































